X4 Pharmaceuticals XFOR
NASDAQ XFOR
$4.04 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Prepaid Assets (2017 - 2026)

X4 Pharmaceuticals' (XFOR) quarterly Prepaid Assets came in at $3.3 million in Q2 2026, down 32.67% on a YoY basis from $5.0 million in Q2 2025, and up 32.84% quarter-over-quarter from $2.5 million in Q1 2026.

Analysis

X4 Pharmaceuticals (XFOR) Prepaid Assets (2017 - 2026) Analysis & Trends

X4 Pharmaceuticals (XFOR) has reported Prepaid Assets for 10 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 32.67% year-over-year to $3.3 million; the trailing twelve-month figure through Jun 2026 stood at $3.3 million (down 32.67% YoY), and the FY2025 full-year result was $3.5 million, down 36.88% from the prior year.
  • Prepaid Assets rose to $3.3 million in Q2 2026 per XFOR's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.3 million in Q4 2023 and bottomed at $2.5 million in Q1 2026.
  • Historically, Prepaid Assets has averaged $4.8 million across 5 years, with a median of $4.9 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Prepaid Assets soared 38.58% in 2024, then plunged 43.97% in 2026.
  • Over 5 years, Prepaid Assets stood at $5.8 million in 2022, then advanced by 25.68% to $7.3 million in 2023, then retreated by 23.43% to $5.6 million in 2024, then slumped by 36.88% to $3.5 million in 2025, then declined by 5.39% to $3.3 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $3.3 million, $2.5 million, and $3.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 X4 Pharmaceuticals 510.43 Mn 315.33 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.34 Mn
Mar 31, 2026 2.51 Mn
Dec 31, 2025 3.53 Mn
Sep 30, 2025 4.93 Mn
Jun 30, 2025 4.96 Mn
Mar 31, 2025 4.48 Mn
Dec 31, 2024 5.59 Mn
Sep 30, 2024 4.48 Mn
Jun 30, 2024 4.98 Mn
Mar 31, 2024 5.76 Mn
Dec 31, 2023 7.30 Mn
Sep 30, 2023 5.80 Mn
Jun 30, 2023 5.52 Mn
Mar 31, 2023 4.16 Mn
Dec 31, 2022 5.81 Mn
Sep 30, 2022 4.95 Mn
Jun 30, 2022 4.36 Mn
Mar 31, 2022 3.59 Mn
Dec 31, 2021 5.34 Mn
Sep 30, 2021 3.66 Mn